Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era

G Goyal, ML Heaney, M Collin… - Blood, The Journal …, 2020 - ashpublications.org
Erdheim-Chester disease (ECD) is a rare histiocytosis that was recently recognized as a
neoplastic disorder owing to the discovery of recurrent activating MAPK (RAS-RAF-MEK …

Histiocytosis

JF Emile, F Cohen-Aubart, M Collin, S Fraitag, A Idbaih… - The Lancet, 2021 - thelancet.com
Histiocytoses constitute a heterogeneous group of rare disorders, characterised by
infiltration of almost any organ by myeloid cells with diverse macrophage or dendritic cell …

The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee

E Campo, ES Jaffe, JR Cook… - Blood, The Journal …, 2022 - ashpublications.org
Since the publication of the Revised European-American Classification of Lymphoid
Neoplasms in 1994, subsequent updates of the classification of lymphoid neoplasms have …

International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults

G Goyal, A Tazi, RS Go, KL Rech… - Blood, The Journal …, 2022 - ashpublications.org
Langerhans cell histiocytosis (LCH) can affect children and adults with a wide variety of
clinical manifestations, including unifocal, single-system multifocal, single-system pulmonary …

Genomic profiling for clinical decision making in lymphoid neoplasms

L De Leval, AA Alizadeh, PL Bergsagel… - Blood, The Journal …, 2022 - ashpublications.org
With the introduction of large-scale molecular profiling methods and high-throughput
sequencing technologies, the genomic features of most lymphoid neoplasms have been …

ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition

PG Kemps, J Picarsic, BH Durham… - Blood, The Journal …, 2022 - ashpublications.org
ALK-positive histiocytosis is a rare subtype of histiocytic neoplasm first described in 2008 in
3 infants with multisystemic disease involving the liver and hematopoietic system. This entity …

SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities

A Andrades, P Peinado, JC Alvarez-Perez… - Molecular cancer, 2023 - Springer
Hematological malignancies are a highly heterogeneous group of diseases with varied
molecular and phenotypical characteristics. SWI/SNF (SWItch/Sucrose Non-Fermentable) …

Dedifferentiated and undifferentiated melanomas: report of 35 new cases with literature review and proposal of diagnostic criteria

A Agaimy, R Stoehr, A Hornung, J Popp… - The American Journal …, 2021 - journals.lww.com
Dedifferentiated melanoma (DM) and undifferentiated melanoma (UM) is defined as a
primary or metastatic melanoma showing transition between conventional and …

[HTML][HTML] RASopathies: from germline mutations to somatic and multigenic diseases

Q Riller, F Rieux-Laucat - biomedical journal, 2021 - Elsevier
Abstract The RAS-RAF-MEK-ERK signaling pathway is vital for different cellular
mechanisms including cell proliferation, differentiation and apoptosis. This importance is …

The SWI/SNF chromatin-remodeling subunit DPF2 facilitates NRF2-dependent antiinflammatory and antioxidant gene expression

G Mas, N Man, Y Nakata, C Martinez-Caja, D Karl… - The Journal of clinical …, 2024 - jci.org
During emergency hematopoiesis, hematopoietic stem cells (HSCs) rapidly proliferate to
produce myeloid and lymphoid effector cells, a response that is critical against infection or …